This report is based on information provided by philips field service engineer (fse) and has been investigated by the philips complaint handling team.Philips received a complaint on the heartstart xl+ indicating that the device is not available even after a battery has been changed.The fse evaluated the device on site.It was determined that this was a malfunction of the therapy pca which was recommended to be replaced to resolve the issue.The customer was informed that service could no longer be completed on the unit as the device had reached end of life (eol).Philips has made the decision to discontinue the heartstart xl+ monitor/defibrillator, which has reached the end of its product life cycle.The last date of shipment for the heartstart xl+ was october, 2017.The end of life (eol) is scheduled globally to end 12/31/2022, where the end of support (eos) period will then begin.Based on the information available and the testing conducted, the cause of the reported problem was a malfunction of the therapy pca.The reported problem was confirmed.The customer was made aware of the end-of-life terms and the device remains at the customer site.The investigation concludes that no further action is required at this time.If additional information is received the complaint file will be reopened.
|